These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11898261)

  • 1. Oxaliplatin. A platinum compound for colorectal cancer?
    Balzer KM
    Cancer Pract; 2000; 8(4):201-3. PubMed ID: 11898261
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxaliplatin: a novel platinum analog with activity in colorectal cancer.
    Berg D
    Oncol Nurs Forum; 2003; 30(6):957-66. PubMed ID: 14603353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer.
    Dragovich T; Mendelson D; Kurtin S; Richardson K; Von Hoff D; Hoos A
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):759-64. PubMed ID: 16847673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oxaliplatin in colorectal cancer].
    Boni C; Banzi M
    Tumori; 2001; 87(1 Suppl 1):S51-2. PubMed ID: 11300025
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
    Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
    Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Platinum drugs].
    Kusaba H; Baba E
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():143-5. PubMed ID: 25831739
    [No Abstract]   [Full Text] [Related]  

  • 7. Advanced colorectal cancer: current treatment and nursing management with economic considerations.
    Viale PH; Fung A; Zitella L
    Clin J Oncol Nurs; 2005 Oct; 9(5):541-52. PubMed ID: 16235581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pain with platinum: oxaliplatin and neuropathy.
    Kiernan MC
    Eur J Cancer; 2007 Dec; 43(18):2631-3. PubMed ID: 17977714
    [No Abstract]   [Full Text] [Related]  

  • 9. Subcutaneous administration of amifostine: a promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy.
    Penz M; Kornek GV; Raderer M; Ulrich-Pur H; Fiebiger W; Scheithauer W
    Ann Oncol; 2001 Mar; 12(3):421-2. PubMed ID: 11332158
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanism of action and pharmacology of new organometallic compounds active in the treatment of colorectal neoplasms].
    Marchetti P; Gallà DA; Cifone G; Ricevuto E; Ficorella C
    Tumori; 2000; 86(3 Suppl):S6-8. PubMed ID: 10969607
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer.
    Lersch C; Schmelz R; Eckel F; Erdmann J; Mayr M; Schulte-Frohlinde E; Quasthoff S; Grosskreutz J; Adelsberger H
    Clin Colorectal Cancer; 2002 May; 2(1):54-8. PubMed ID: 12453338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaliplatin: a review of its use in the management of metastatic colorectal cancer.
    Wiseman LR; Adkins JC; Plosker GL; Goa KL
    Drugs Aging; 1999 Jun; 14(6):459-75. PubMed ID: 10408744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer.
    Argyriou AA; Cavaletti G; Briani C; Velasco R; Bruna J; Campagnolo M; Alberti P; Bergamo F; Cortinovis D; Cazzaniga M; Santos C; Papadimitriou K; Kalofonos HP
    Cancer; 2013 Jan; 119(2):438-44. PubMed ID: 22786764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study.
    Suenaga M; Mizunuma N; Matsusaka S; Shinozaki E; Ozaka M; Ogura M; Yamaguchi T
    Drug Des Devel Ther; 2015; 9():3099-108. PubMed ID: 26124634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxaliplatin: a review of approved uses.
    Stein A; Arnold D
    Expert Opin Pharmacother; 2012 Jan; 13(1):125-37. PubMed ID: 22149372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral neuropathy in patients with colorectal cancer receiving oxaliplatin.
    Tofthagen C; McAllister RD; McMillan SC
    Clin J Oncol Nurs; 2011 Apr; 15(2):182-8. PubMed ID: 21444285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles Loaded with Platinum Drugs for Colorectal Cancer Therapy.
    Buyana B; Naki T; Alven S; Aderibigbe BA
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oxaliplatin: the first DACH platinum in clinical practice].
    Soulié P; Raymond E; Brienza S; Cvitkovic E
    Bull Cancer; 1997 Jun; 84(6):665-73. PubMed ID: 9295871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer.
    Leonard GD; Wright MA; Quinn MG; Fioravanti S; Harold N; Schuler B; Thomas RR; Grem JL
    BMC Cancer; 2005 Sep; 5():116. PubMed ID: 16168057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of chemotherapy-induced peripheral sensory neuropathy, focusing on oxaliplatin.
    Gent P; Massey K
    Int J Palliat Nurs; 2001 Jul; 7(7):354-9. PubMed ID: 11951404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.